AptarGroup, Inc. (ATR) Stock Analysis
Healthcare · Medical Instruments & Supplies
Wait for pullback to $122.90. Weak momentum — blocks BUY_NOW at $124.68. Engine's entry $122.90 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum.
AptarGroup designs and manufactures drug and consumer product dosing, dispensing, and protection technologies including pumps, aerosol valves, elastomeric pharma packaging, and digital health solutions, serving pharmaceutical, fragrance, food, and personal care markets globally... Read more
Wait for pullback to $122.90. Weak momentum — blocks BUY_NOW at $124.68. Engine's entry $122.90 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Earnings in 0 days. Wait until post-earnings. Score 5.1/10, moderate confidence.
Passes 4/6 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and earnings proximity 0d<=7d. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMSuppliersingle-source resins and rubber components10-K Item 1A: 'we have historically sourced certain materials, especially some resins and rubber components for our Pharma segment, from a single source'
Material Events(8-K, last 90d)
- 2026-03-17Item 5.02MEDIUMCEO Stephan Tanda notified the Board of intent to retire effective September 1, 2026. Gael Touya (President, Aptar Pharma) appointed as successor CEO effective same date. Clean handoff with named successor.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $122.90. Weak momentum — blocks BUY_NOW at $124.68. Engine's entry $122.90 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Earnings in 0 days. Wait until post-earnings. Target $141.56 (+13.5%), stop $116.39 (−7.1%), Setup A.R:R 3.4:1. Score 5.1/10, moderate confidence.
Take-profit target: $141.56 (+14.6% upside). Target $141.56 (+13.5%), stop $116.39 (−7.1%), Setup A.R:R 3.4:1. Stop-loss: $116.39.
AptarGroup, Inc. trades at a P/E of 20.9 (forward 19.3). TrendMatrix value score: 5.9/10. Verdict: Buy (Wait for Entry).
12 analysts cover ATR with a consensus score of 4.1/5. Average price target: $163.
What does AptarGroup, Inc. do?AptarGroup designs and manufactures drug and consumer product dosing, dispensing, and protection technologies including...
AptarGroup designs and manufactures drug and consumer product dosing, dispensing, and protection technologies including pumps, aerosol valves, elastomeric pharma packaging, and digital health solutions, serving pharmaceutical, fragrance, food, and personal care markets globally with approximately 14,000 employees in ~20 countries. No single customer accounts for more than 4% of 2025 Net Sales.